NCT00604409View on ClinicalTrials.gov

Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

June 30, 2014

Study Completion Date

January 31, 2015

Conditions
Metastatic Liver Cancer
Interventions
RADIATION

SIRT

Undergo SIRT

DRUG

capecitabine

Given PO

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

Sponsors

Collaborators (1)

Sirtex Medical
All Listed Sponsors
collaborator

Sirtex Medical

INDUSTRY

lead

Fox Chase Cancer Center

OTHER

NCT00604409 - Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter